Elon Musk’s Neuralink has implanted its computer chip in a human test subject, marking a significant development in Brain-Computer Interface (BCI) research. The first human subject is reportedly recovering well, and initial results show promising neuron spike detection. Neuralink aims to decode intended movement signals from brain activity, enabling control of external devices by thinking. Musk envisions telepathy as the first product, allowing users to control phones or computers through thought, with initial applications for individuals who have lost the use of their limbs. Neuralink received FDA approval in September for human trials, targeting those with quadriplegia.
Neuralink’s achievement demonstrates the progress in BCI technology, aiming to empower individuals with limited physical capabilities. The focus on telepathy as an application showcases the potential for technology to enhance communication and control devices through thought. The voluntary human trials, despite potential controversies, reflect the commitment to advancing medical technology for therapeutic purposes. The broader implications of BCI technology extend to improving the quality of life for individuals with neurological conditions and spinal cord injuries. (Source: decrypt.co)
